People really aren't taking this PR really serious. Just in 2015 alone, over 77,000 cases of invasive melanoma were diagnosed in just the United States alone. In 2019, that number has risen to close to 100,000 (in situ). Even skincancer.org cites it being over 190,000 cases in 2019. Moreover, 9,900 people will die from it according to a publication named "Cost-effective Melanoma Screening" by Dr. Robinson and Halpern (2016). Now, it has dropped to 7,700 roughly (2019).
Roughly 9,500 people are diagnosed ever day (nonmelanoma and melanoma skin cancer, not to be confused from above), 5.4 million cases from 3.3 million people.
The total cost for treating individuals with Melanoma per year:
I can't seem to get a total screening of Americans that get tested every year for skin cancer but it would be safe to say that its in the hundreds of thousands, if not a couple million in the U.S. alone. And if this biopsy costs $200 just to determine if one has melanoma or nonmelanoma, it quickly adds up.
So a non-invasive method of detection that is painless is astounding seeing all other detection methods require a physical sample to be removed. This may lower the costs or be close to the same. This is worth 10s, if not, 100s of millions of dollars per year. Or a slice of the pie if ever implemented and used.
Pretty crazy stuff. Yet, here we are with no action.
Signet acquired the rights to the patent from The Univ Of Florida. They have some of the best inventors in the U.S.
Many times the Government funds these research projects "patents" with Federal Grant Money. This project must have cost a lot of money to develop and obtain this patent. I researched this patent and it is one of a kind.
From my DD they are working with at least three different Universities in Florida. All three of them are top notch for research and patent development.
I'm not exactly sure how they were able to do that. Very impressive.
Market Data 
Markets 
AI
